[ad_1]
Delta Air Lines’ stock took a dive toward a four-month low in premarket trading Thursday, after the air carrier reported second-quarter profit and load factor that missed expectations, and provided a downbeat revenue outlook.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...